Prosecution Insights
Last updated: October 26, 2026

Philip Charles Edwards, USPTO Patent Examiner

Listed by the USPTO as EDWARDS, PHILIP CHARLES

Tech Center 3700 • Art Units: 3762 3792

This examiner grants 85% of resolved cases

Analysis

EDWARDS, PHILIP CHARLES is a USPTO patent examiner in Tech Center 3700 and Art Unit 3762. The profile reports 539 resolved cases, an allowance rate of 85.0%, and an interview lift of 15.5%. Median time to allowance is 895 days. These measures provide a substantial reference for setting prosecution expectations, while the interview figure supports using examiner discussions where they address issues not fully resolved in writing.

Representative companies are Theragen, Inc., The Regents of the University of California, and Medtronic Inc. Representative firms are Farber LLC, Aurora Consulting LLC, and Bookoff McAndrews, PLLC. Counsel can use the profile to align claim strategy, technical submissions, and client communication with the observed record.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

85.0%
Allow Rate
+15.0% vs TC avg
592
Total Applications
+15.5%
Interview Lift
895
Avg Prosecution Days
Based on 539 resolved cases, 2023–2026

Rejection Statute Breakdown

5.3%
§101 Eligibility
29.4%
§102 Novelty
52.5%
§103 Obviousness
10.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18812491 SEIZURE DETECTION Final Rejection Samsung Electronics Co., Ltd.
18375826 CONTROLLING OPTICAL POWER IN A SENSOR WITH THE USE OF A FARADAY CAGE Non-Final OA COVIDIEN LP
19109537 Systems and Methods for Wirelessly Powered Sources with Programmable Amplitude and Spectrum Spreading Using Pulse Width Modulation Non-Final OA The Regents of the University of California
18544206 Method of Neural Intervention for the Treatment of Affective Neuropsychiatric Disorders Final Rejection The Regents of the University of California
18909457 FAST IDENTIFICATION OF SHOCKABLE OR NON-SHOCKABLE RHYTHMS IN ECG DATA Final Rejection ZOLL Medical Corporation
18131614 SYSTEMS AND METHODS FOR STIMULATING OR BLOCKING A NERVE USING AN ELECTRODE DEVICE WITH A SUTURELESS CLOSURE Non-Final OA Medtronic, Inc.
18101885 THERAPEUTIC ELECTRODE LOCATION PREDICTION VISUALIZATION USING MACHINE LEARNING Final Rejection Medtronic, Inc.
18780219 LIGHT THERAPY SYSTEM AND METHOD Final Rejection KORRUS, INC.
17065476 SYSTEMS AND METHODS OF REMOTE EXTRACTION OF SKELETAL INFORMATION USING MILLIMETER WAVE RADAR Final Rejection ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
18274613 DEVICE FOR CARRYING OUT A TVNS TREATMENT Final Rejection tVNS Technologies GmbH
18357613 SYSTEMS AND METHODS FOR HUMAN-MACHINE PARTNERED PTSD PREDICTION Final Rejection The MITRE Corporation

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Philip Charles Edwards's allowance rate?

85.0% of resolved applications examined by Philip Charles Edwards were allowed (539 resolved cases), compared with 57.3% across Art Unit 3762 over the last five years.

Does an interview help with examiner Philip Charles Edwards?

This examiner's interview lift is +15.5 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Philip Charles Edwards take to allow a patent?

Applications allowed by Philip Charles Edwards took 895 days on average from filing to allowance.

Which art unit does examiner Philip Charles Edwards work in?

Philip Charles Edwards examines applications in Art Unit 3762 in Tech Center 3700 (Medical Devices & Mechanical Engineering).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month